Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Esquire Financial Holdings
ESQ
$1.14B
| $2.69M | ﹤0.01% |
+140,454
| New | +$2.52M |
|
3452
Oxford Industries
OXM
$552M
| $2.69M | ﹤0.01% |
41,137
-80,016
| -66% | -$4.14M |
|
3453
Forrester Research
FORR
$224M
| $2.69M | ﹤0.01% |
64,235
-20,749
| -24% | -$829K |
|
3454
Lifecore Biomedical
LFCR
$190M
| $2.69M | ﹤0.01% |
247,585
+39,528
| +19% | +$408K |
|
3455
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.02B
| $2.68M | ﹤0.01% |
52,932
-57,750
| -52% | -$2.62M |
|
|
HIBB
3456
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.68M | ﹤0.01% |
57,938
-158,242
| -73% | -$7.07M |
|
3457
AppFolio
APPF
$7.04B
| $2.67M | ﹤0.01% |
14,854
-3,331
| -18% | -$533K |
|
3458
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
| $2.67M | ﹤0.01% |
166,432
-800,000
| -83% | -$12.1M |
|
|
CMLFU
3459
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
| $2.67M | ﹤0.01% |
+230,000
| New | +$2.48M |
|
|
TRIL
3460
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.66M | ﹤0.01% |
+180,700
| New | +$2.61M |
|
3461
Olema Pharmaceuticals
OLMA
$1.05B
| $2.65M | ﹤0.01% |
+55,165
| New | +$2.59M |
|
|
TBI
3462
Trueblue
TBI
$311M
| $2.65M | ﹤0.01% |
141,905
-199,633
| -58% | -$3.59M |
|
3463
Parke Bancorp
PKBK
$405M
| $2.65M | ﹤0.01% |
+169,892
| New | +$2.42M |
|
3464
SK Telecom
SKM
$13.2B
| $2.65M | ﹤0.01% |
65,691
-10,789
| -14% | -$415K |
|
3465
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.41B
| $2.65M | ﹤0.01% |
31,857
-100
| -0.3% | -$7.57K |
|
|
OPI
3466
DELISTED
Office Properties Income Trust
OPI
| $2.64M | ﹤0.01% |
116,307
-69,188
| -37% | -$1.51M |
|
3467
ICL Group
ICL
$6.85B
| $2.64M | ﹤0.01% |
523,078
-335,877
| -39% | -$1.4M |
|
|
ETAC
3468
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
| $2.63M | ﹤0.01% |
+257,000
| New | +$2.53M |
|
3469
Evolent Health
EVH
$447M
| $2.62M | ﹤0.01% |
163,150
+87,315
| +115% | +$1.15M |
|
3470
Fortuna Silver Mines
FSM
$3.07B
| $2.61M | ﹤0.01% |
316,645
-37,695
| -11% | -$261K |
|
3471
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$161M
| $2.6M | ﹤0.01% |
27,779
| – | – |
|
3472
CALL
QuantumScape Corp
QS
$3.74B
| $2.59M | ﹤0.01% |
+30,700
| New | +$1.12M |
|
|
AMWD
3473
DELISTED
American Woodmark
AMWD
| $2.59M | ﹤0.01% |
27,620
-4,564
| -14% | -$415K |
|
3474
908 Devices
MASS
$364M
| $2.59M | ﹤0.01% |
+45,451
| New | +$2.65M |
|
3475
Vitamin Cottage Natural Grocers
NGVC
$654M
| $2.59M | ﹤0.01% |
188,366
+5,370
| +3% | +$66.9K |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.